Omicron News and Research

RSS

Should siRNA-based antivirals be added to the COVID toolbox?

A recent study reviewed the existing treatment modalities, including vaccines and antivirals, for SARS-CoV-2 infection.

19 Jul 2022

Study quantifies the likelihood of future COVID-19 following natural infection or vaccination

Since COVID-19 vaccines first became available to protect against infection and severe illness, there has been much uncertainty about how long the protection lasts, and when it might be necessary for individuals to get an additional booster shot.

18 Jul 2022

What is the impact of lower COVID-19 vaccine doses in younger cohorts?

A new study evaluated the impact of the lower SARS-CoV-2 vaccine dosages in younger populations.

18 Jul 2022

How effective is previous infection in preventing reinfection with Omicron BA.4/BA.5?

Researchers investigated the protection conferred by previous SARS-CoV-2 infection in preventing reinfection with BA.4 or BA.5 Omicron subvariants in the residents of Qatar.

18 Jul 2022

Scientists evaluate immunostimulatory glycolipid against SARS-CoV-2 infection

A new study showed that 7DW8-5, an immunostimulatory glycolipid impeded three respiratory viral infections, including SARS-CoV-2, in vivo.

18 Jul 2022

Boost now or wait? Many wonder how best to ride out covid’s next wave

Gwyneth Paige didn't want to get vaccinated against covid-19 at first. With her health issues — hypertension, fibromyalgia, asthma — she wanted to see how other people fared after the shots. Then her mother got colon cancer.

18 Jul 2022

Researchers develop a rapid, specific, and accurate RT-qPCR-based method to detect and distinguish between Omicron sublineages

Researchers developed a novel, rapid and accurate qRT-PCR-based method to detect Omicron sublineages BA.1/BA.1.1 and BA.2 in patient samples.

18 Jul 2022

How effective is the fourth dose of COVID-19 vaccines in the elderly and long-term care residents?

Researchers evaluated the efficacy of the fourth dose of coronavirus disease 2019 vaccine in residents of long-term care facilities.

18 Jul 2022

The potential of circular RNA COVID-19 vaccines

A new MedComm study describes the potential use of circular ribonucleic acid COVID-19 vaccines.

17 Jul 2022

The disease burden and clinical severity of the SARS-CoV-2 Omicron BA.2 sublineage outbreak in Shanghai

Researchers estimated the severity and burden of COVID-19 in a recent outbreak in Shanghai, China.

14 Jul 2022

SARS-Arena reveals conserved parts of viral proteins that cause COVID-19

Vaccines may need to dig a little deeper to stop SARS-CoV-2. Rice University researchers are providing a new shovel.

14 Jul 2022

Study provides detailed understanding of SARS-CoV-2 Omicron sublineage antibody escape

A new study reveals the antibody-mediated neutralization of both current and emerging Omicron subvariants.

13 Jul 2022

GenomeBits representation of SARS-CoV-2 Delta and Omicron genome sequences

In a new study, researchers uncovered distinct genomic features of SARS-CoV-2 Delta and Omicron variants.

13 Jul 2022

Evolutionary characteristics of the SARS-CoV-2 Omicron variant

Researchers compared the mutations in the SARS-CoV-2 Omicron variant with others to highlight their evolutionary differences.

13 Jul 2022

Study suggests ZCB11 as a promising antibody drug against all SARS-CoV-2 variants of concern

Researchers at the AIDS Institute, The University of Hong Kong, Department of Microbiology, School of Clinical Medicine, the LKS Faculty of Medicine of The University of Hong Kong and the State Key Laboratory of Emerging Infectious Diseases, HKU, together with structural biologists at The Hong Kong University of Science and Technology, have demonstrated that ZCB11, a broadly neutralizing antibody derived from a local mRNA-vaccinee against the spreading Omicron variants of SARS-CoV-2, displays potent antiviral activities against all variants of concern (VOCs), including the dominantly spreading Omicron BA.1, BA1.1 and BA.2.

13 Jul 2022

Omicron News and Research

Should siRNA-based antivirals be added to the COVID toolbox?

Study quantifies the likelihood of future COVID-19 following natural infection or vaccination

What is the impact of lower COVID-19 vaccine doses in younger cohorts?

How effective is previous infection in preventing reinfection with Omicron BA.4/BA.5?

Scientists evaluate immunostimulatory glycolipid against SARS-CoV-2 infection

Boost now or wait? Many wonder how best to ride out covid’s next wave

Researchers develop a rapid, specific, and accurate RT-qPCR-based method to detect and distinguish between Omicron sublineages

How effective is the fourth dose of COVID-19 vaccines in the elderly and long-term care residents?

The potential of circular RNA COVID-19 vaccines

The disease burden and clinical severity of the SARS-CoV-2 Omicron BA.2 sublineage outbreak in Shanghai

SARS-Arena reveals conserved parts of viral proteins that cause COVID-19

Study provides detailed understanding of SARS-CoV-2 Omicron sublineage antibody escape

GenomeBits representation of SARS-CoV-2 Delta and Omicron genome sequences

Evolutionary characteristics of the SARS-CoV-2 Omicron variant

Study suggests ZCB11 as a promising antibody drug against all SARS-CoV-2 variants of concern

The potential of tixagevimab–cilgavimab for treating hospitalized COVID-19 patients

Immunoglobulin G isotypes switch class following repeated SARS-CoV-2 mRNA vaccination

Booster dose of SARS-CoV-2 vaccine benefits lupus patients

Detection of SARS-CoV-2 variants in aircraft wastewater

Scientists explore antigenic imprinting in SARS-CoV-2

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News